Displaying 1 - 12 of 22
Metabolism, Alcohol & Toxicity

Rising to the Need to Improve Diagnosis in the Era of Disease-specific Therapy

Webcasts
View
Metabolism, Alcohol & Toxicity

Q&A

Webcasts
View
Metabolism, Alcohol & Toxicity

Integrating MASLD/MASH-Specific Therapy into Guideline-Aligned Real-World Practice

Webcasts
View
Metabolism, Alcohol & Toxicity

Changing the MASH Paradigm With THR-β Agonists and Other Disease-Specific Therapies

Webcasts
View
Metabolism, Alcohol & Toxicity

AKH: A New Era in MASH: How Disease-Specific Therapies Are Changing the Game and Best Practices for Clinical Integration (Comp...

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Albireo Pharma, an Ipsen Company: “New Horizons in cholestatic liver disease” (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Madrigal Pharmaceuticals: "Emerging role of the hepatic thyroid pathway in the pathophysiology of NASH" (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Discussion and Q&A

Webcasts
View
Metabolism, Alcohol & Toxicity

Introduction

Webcasts
View
Metabolism, Alcohol & Toxicity

NASH: a growing unmet therapeutic need

Webcasts
View
Metabolism, Alcohol & Toxicity

The underestimated role of thyroid hormone pathway in the pathophysiology of NASH

Webcasts
View
Metabolism, Alcohol & Toxicity

Key take home messages and close

Webcasts
View
Displaying 1 - 12 of 22